Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...
Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...
Planegg/Martinsried, 22 June 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid ...
Cancer immunotherapy approaches such as adoptive transfer of chimeric antigen receptor (CAR) T cells or tumor-infiltrating lymphocytes have yielded promising results in hematological malignancies.
Asianet Newsable on MSN
Common Nutrient Zeaxanthin Could Strengthen T Cells Against Cancer
Zeaxanthin, a nutrient found in spinach and peppers, boosts T-cell cancer-fighting power. New research shows it could enhance ...
Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it ...
Oslo, Norway, 10 September 2025 - Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, announces an ...
Its End-to-End Platform generates optimal 3S (sensitive, specific and safe) T cell receptors with unique and distinctive attributes that are utilized in multiple therapeutic modalities, such as T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback